- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06457841
Stress and Resilience (BARS)
July 10, 2025 updated by: Priscilla Lui, University of Washington
Black Adult Resilience Study
Alcohol and cannabis are the most misused psychoactive substances in the United States.
The proposed research examines how personally relevant stressful experiences may lead to alcohol and cannabis use.
The proposed research is also designed to identify possible targets for prevention and treatment efforts to help reduce drug use.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
456
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: P. Priscilla Lui, Ph.D.
- Phone Number: 206-685-8391
- Email: pplui@uw.edu
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75204
- Recruiting
- Southern Methodist University
-
Contact:
- Ernest N Jouriles, Ph.D.
- Phone Number: 214-768-2360
- Email: ejourile@smu.edu
-
-
Washington
-
Seattle, Washington, United States, 98195
- Recruiting
- University of Washington
-
Contact:
- P. Priscilla Lui, Ph.D.
- Phone Number: 206-685-8391
- Email: pplui@uw.edu
-
Sub-Investigator:
- Kevin M King, Ph.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Of Afro-descent
- Proficient in English
- Alcohol and/or cannabis use at least 2-3 times in the past month
- Endorse having used alcohol and/or cannabis to cope
Exclusion Criteria:
- Having participated in similar studies by the research team
- Obtain cut-off scores on scale items indicating possible loss of control and needing to cut down or quit alcohol and/or cannabis use
- In or seeking treatment for alcohol and/or cannabis use disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Direct Interpersonal Exchange
Simulated a negative personally relevant interpersonal experience that is received directly from a perpetrator, commonly experienced in everyday lives
|
Simulated a negative personally relevant interpersonal experience that is received directly from a perpetrator, commonly experienced in everyday lives
|
|
Experimental: Vicarious Interpersonal Exchange
Hearing or observing a negative personally relevant interpersonal experience that is reported by another person of the same background
|
Hearing or observing a negative personally relevant interpersonal experience that is reported by another person of the same background
|
|
Placebo Comparator: Daily Hassles
Day-to-day stressors associated with school, work, finances
|
Day-to-day stressors associated with school, work, finances
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of Alcohol and Cannabis Intoxication
Time Frame: 48 Hours Post-Intervention
|
Self-reported number of hours of intoxication within 48 hours after the intervention
|
48 Hours Post-Intervention
|
|
Momentary Alcohol and/or Cannabis Craving
Time Frame: Immediately after the intervention (i.e., within 1 minute)
|
Momentary Alcohol and Cannabis Craving Scale will be administered (adapted from the Momentary Cannabis Craving Scale; Davis et al., 2024) immediately after the intervention.
Mean scores will range from 1 to 7, with higher scores indicating greater momentary craving.
|
Immediately after the intervention (i.e., within 1 minute)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: P. Priscilla Lui, Ph.D., University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 9, 2024
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Study Registration Dates
First Submitted
May 28, 2024
First Submitted That Met QC Criteria
June 7, 2024
First Posted (Actual)
June 13, 2024
Study Record Updates
Last Update Posted (Actual)
July 15, 2025
Last Update Submitted That Met QC Criteria
July 10, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00018058
- R01DA058626 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use
-
Women's College HospitalRecruitingAlcohol; Harmful Use | Tobacco Use | Tobacco Use Cessation | Alcohol Use, UnspecifiedCanada
-
University of Central FloridaEnrolling by invitationAlcohol Use, Underage | Harmful; Use, AlcoholUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institutes of Health (NIH); National Center for Complementary and...CompletedTobacco Use | Alcohol Use, UnspecifiedUnited States
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
-
University of Colorado, DenverUnknownAlcohol Use Disorders | Unhealthy Alcohol UseUnited States
-
University of WashingtonUniversity of North Texas Health Science CenterCompletedRisk-Taking | Underage Alcohol Use | Feedback, PsychologicalUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
Clinical Trials on Daily Hassles
-
University of North Carolina, Chapel HillYale University; Rush University Medical Center; Dartmouth-Hitchcock Medical... and other collaboratorsRecruitingPleural Effusion | Empyema, Pleural | Empyema | Pleural Effusion Associated With Pulmonary Infection | Complicated Pleural Effusion/ Empyema | Pleural Infection Bacterial | Pleural Infections and Inflammations | Pleural InfectionsUnited States
-
Cornell UniversityCompleted
-
University of DelawareCompletedDaily Self-weighing | Daily Temperature-takingUnited States
-
Dr. Reddy's Laboratories LimitedCompleted
-
University of AarhusIndependent Research Fund DenmarkRecruitingSleep | Circadian Rhythms | Time PerceptionDenmark
-
Peking University People's HospitalCompleted
-
Boehringer IngelheimCompletedAsthmaUnited States, Austria, Germany, Hungary, Slovakia, Slovenia
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Örebro University, SwedenRecruitingHealthy ParticipantsSweden
-
Spectrum Pharmaceuticals, IncTerminated